JDMRX | SEPKX | JDMRX / SEPKX | |
Total Expense Ratio | 1.42 | 1.10 | 129% |
Annual Report Gross Expense Ratio | 1.42 | 1.16 | 122% |
Fund Existence | 16 years | 23 years | - |
Gain YTD | 5.551 | 14.643 | 38% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.4B | 654M | 3,578% |
Annual Yield % from dividends | 0.56 | 0.00 | - |
Returns for 1 year | 2.26 | 14.51 | 16% |
Returns for 3 years | 10.18 | 42.40 | 24% |
Returns for 5 years | -1.95 | -7.69 | 25% |
Returns for 10 years | 53.71 | 29.68 | 181% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 23.00 | 0.43 | +1.91% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
LFSC | 28.94 | 0.41 | +1.44% |
F/m Emerald Life Sciences Innovation ETF | |||
PIZ | 46.31 | 0.33 | +0.72% |
Invesco DW Developed Markets Momt ETF | |||
CGCB | 26.61 | 0.10 | +0.38% |
Capital Group Core Bond ETF | |||
QRMI | 15.79 | 0.01 | +0.10% |
Global X NASDAQ 100® Risk Mngd Inc ETF |